Paper42152256
Chemical Synthesis and Biochemical Evaluation of Decasulfated Galloylglucopyranose Heparin Mimetic.
Al-Horani RA. Cardiovasc Hematol Agents Med Chem, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Chemical Synthesis and Biochemical Evaluation of Decasulfated Galloylglucopyranose Heparin Mimetic. Papers, record 42152256. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42152256
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Chemical Synthesis and Biochemical Evaluation of Decasulfated Galloylglucopyranose Heparin Mimetic.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R16 GM149412 | NIGMS NIH HHS | United States | R16GM149412 | PubMed |
Source NIH RePORTER
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 41406988 | Trends and variation in the use of andexanet alfa for the reversal of direct oral anticoagulants in NHS trusts in England. | Br J Clin Pharmacol | 2026 | https://conductscience.org/library/papers/41406988 | PubMed |
| 2 | 24968014 | Synthetic, non-saccharide, glycosaminoglycan mimetics selectively target colon cancer stem cells. | ACS Chem Biol | 2014 | https://conductscience.org/library/papers/24968014 | PubMed |
| 3 | 38500048 | European expert consensus recommendations on the primary care use of direct oral anticoagulants in patients with venous thromboembolism. | BMC Prim Care | 2024 | https://conductscience.org/library/papers/38500048 | PubMed |
| 4 | 25935648 | Allosteric inhibition of factor XIa. Sulfated non-saccharide glycosaminoglycan mimetics as promising anticoagulants. | Thromb Res | 2015 | https://conductscience.org/library/papers/25935648 | PubMed |
| 5 | 41298028 | Venous Thromboembolism: Global Burden of Disease Estimates Are Missing a Common Cardiovascular Condition. | J Am Coll Cardiol | 2025 | https://conductscience.org/library/papers/41298028 | PubMed |
| 6 | 31935028 | Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial. | JAMA | 2020 | https://conductscience.org/library/papers/31935028 | PubMed |
| 7 | 30046683 | Impact of World Thrombosis Day campaign. | Res Pract Thromb Haemost | 2017 | https://conductscience.org/library/papers/30046683 | PubMed |
| 8 | 28693366 | Idarucizumab for Dabigatran Reversal - Full Cohort Analysis. | N Engl J Med | 2017 | https://conductscience.org/library/papers/28693366 | PubMed |
| 9 | 31104194 | Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism. | J Thromb Thrombolysis | 2019 | https://conductscience.org/library/papers/31104194 | PubMed |
| 10 | 25325944 | Synthesis of glycosaminoglycan mimetics through sulfation of polyphenols. | Methods Mol Biol | 2015 | https://conductscience.org/library/papers/25325944 | PubMed |
| 11 | 34780683 | Milvexian for the Prevention of Venous Thromboembolism. | N Engl J Med | 2021 | https://conductscience.org/library/papers/34780683 | PubMed |
| 12 | 37001055 | Designing Smaller, Synthetic, Functional Mimetics of Sulfated Glycosaminoglycans as Allosteric Modulators of Coagulation Factors. | J Med Chem | 2023 | https://conductscience.org/library/papers/37001055 | PubMed |
| 13 | 41589825 | Accuracy of HAS-BLED and BleedMAP Scores in Predicting Postoperative Bleeding in Anticoagulated Patients Undergoing non-Cardiac Surgery. | Clin Appl Thromb Hemost | 2026 | https://conductscience.org/library/papers/41589825 | PubMed |
| 14 | 37037122 | Factor XIa Inhibitors in Anticoagulation Therapy: Recent Advances and Perspectives. | J Med Chem | 2023 | https://conductscience.org/library/papers/37037122 | PubMed |
| 15 | 31397071 | A synthetic heparin mimetic that allosterically inhibits factor XIa and reduces thrombosis in vivo without enhanced risk of bleeding. | J Thromb Haemost | 2019 | https://conductscience.org/library/papers/31397071 | PubMed |
| 16 | 23316863 | Sulfated pentagalloylglucoside is a potent, allosteric, and selective inhibitor of factor XIa. | J Med Chem | 2013 | https://conductscience.org/library/papers/23316863 | PubMed |
| 17 | 31446606 | Reversal agents for oral anticoagulant-associated major or life-threatening bleeding. | Intern Emerg Med | 2019 | https://conductscience.org/library/papers/31446606 | PubMed |
| 18 | 26862063 | Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices? | Am J Cardiovasc Drugs | 2016 | https://conductscience.org/library/papers/26862063 | PubMed |
| 19 | 29105079 | Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease. | Cochrane Database Syst Rev | 2017 | https://conductscience.org/library/papers/29105079 | PubMed |
| 20 | 28069637 | Oral anticoagulation in end-stage renal disease and atrial fibrillation: is it time to just say no to drugs? | Heart | 2017 | https://conductscience.org/library/papers/28069637 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| F10 | 2159 | PubTator's text mining | https://conductscience.org/library/genes/2159 | NCBI Gene |
| F2 | 2147 | PubTator's text mining | https://conductscience.org/library/genes/2147 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42152256
GET https://conductscience.org/api/papers/v1/42152256/references?page=2